rabies immunoglobulin - medicine shortage information

Back to CRITICAL Shortages     Back to ALL Shortages

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist. In most cases your doctor and pharmacist will know about the possible substitute medicines to continue your care.

In some cases the Supply Detail section below will provide information about the special arrangements that are in place for your health professional to prescribe or supply a substitute medicine. These may include reference to Special Access Scheme or "Under section 19A"

Product details Supply Impact Dates Further Details
IMOGAM RABIES PASTEURIZED human rabies immunoglobulin 150 IU/mL injection vial
AUST R: 72931
Active ingredients:
rabies immunoglobulin

Sponsor:
Sanofi-Aventis Australia Pty Ltd

Phone:
1800818806

Deletion from market:
01 Jan 2022

Status:
Discontinued

Patient impact:
Critical

Availability:
Limited Availability

Reason:
Other

TGA Management Actions:
An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.